Com cada any, el curs de malalties neuromusculars que es farà el 25, 26 i 27 de maig a l’Hospital de Sant Pau, reunirà professionals interessats en la patologia neuromuscular.
Durant tres dies intensos es faran classes sobre els grans grups de patologia neuromuscular. Aquestes classes són realitzades per experts nacionals i internacionals en cada tema. Els tallers es faran a la tarda, aprofundint en aspectes més tècnics i proves diagnòstiques fonamentals en aquestes patologies.
Com cada any, el curs de malalties neuromusculars que es farà el 25, 26 i 27 de maig a l’Hospital de Sant Pau, reunirà professionals interessats en la patologia neuromuscular.
Durant tres dies intensos es faran classes sobre els grans grups de patologia neuromuscular. Aquestes classes són realitzades per experts nacionals i internacionals en cada tema. Els tallers es faran a la tarda, aprofundint en aspectes més tècnics i proves diagnòstiques fonamentals en aquestes patologies.
Article Complet
20
Mar
2022
Des de la Unitat de Malalties Neuromusculars de l’Hospital de Sant Pau lamentem comunicar-vos la trista notícia de la mort de la Dra Isabel Illa, fundadora i Directora de la Unitat, Catedràtica de Neurologia, pionera en el camp de les malalties neuromusculars al nostre país, mestra i mentora de molts de nosaltres. DEP.
Des de la Unitat de Malalties Neuromusculars de l’Hospital de Sant Pau lamentem comunicar-vos la trista notícia de la mort de la Dra Isabel Illa, fundadora i Directora de la Unitat, Catedràtica de Neurologia, pionera en el camp de les malalties neuromusculars al nostre país, mestra i mentora de molts de nosaltres. DEP.
Article Complet
La preinscripción para el X curso de Formación en Enfermedades Neuromusculares ya está abierta.
Este curso gratuito que se celebra en el Hospital de la Santa Creu i Sant Pau vuelve a ser presencial, salvo imprevistos, y tendrá lugar los días 25, 26 y 27 de Mayo de 2022.
La preinscripción para el X curso de Formación en Enfermedades Neuromusculares ya está abierta.
Este curso gratuito que se celebra en el Hospital de la Santa Creu i Sant Pau vuelve a ser presencial, salvo imprevistos, y tendrá lugar los días 25, 26 y 27 de Mayo de 2022.
Article Complet
La Dra. Lorena Martín Aguilar, investigadora del Grup de Malalties Neuromusculars de l’Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, ha estat reconeguda amb el Premi Richard A.C. Hughes en el marc de la reunió anual de la Peripheral Nerve Society.
La Dra. Lorena Martín Aguilar, investigadora del Grup de Malalties Neuromusculars de l’Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, ha estat reconeguda amb el Premi Richard A.C. Hughes en el marc de la reunió anual de la Peripheral Nerve Society.
Article Complet
El passat divendres 28 de maig va concloure la IX edició del Curs de Malalties Neuromusculars impulsat per la Unitat de Malalties Neuromusculars de l’Hospital de la Santa Creu i Sant Pau i que compta cada any amb la col·laboració de grans professionals d’arreu d’España en aquest camp de malalties. Un curs on els assistents profunditzen de forma intensa en els coneixements d’aquestes malalties a través de classes tant teòriques com pràctiques.
El passat divendres 28 de maig va concloure la IX edició del Curs de Malalties Neuromusculars impulsat per la Unitat de Malalties Neuromusculars de l’Hospital de la Santa Creu i Sant Pau i que compta cada any amb la col·laboració de grans professionals d’arreu d’España en aquest camp de malalties. Un curs on els assistents profunditzen de forma intensa en els coneixements d’aquestes malalties a través de classes tant teòriques com pràctiques.
Article Complet
Després d’una primera setmana teòrica, el passat divendres 14 de Maig es va realitzar la primera sessió en streaming on els alumnes van poder interactuar en directe amb els professionals en Malalties Neuromusculars.
Després d’una primera setmana teòrica, el passat divendres 14 de Maig es va realitzar la primera sessió en streaming on els alumnes van poder interactuar en directe amb els professionals en Malalties Neuromusculars.
Article Complet
Amb motiu del Dia Nacional de la Miastènia Gravis l’Associació de pacients AMES ha organitzat un seguit d’activitats informatives per donar visibilitat a aquesta malaltia.
La miastènia greu (MG) és una malaltia neuromuscular poc freqüent que es caracteritza perquè els pacients tenen fatigabilitat i debilitat dels músculs voluntaris. La debilitat pot afectar qualsevol múscul incloent músculs oculars, de les extremitats i músculs vitals, responsables de la funció respiratòria, de la deglució i de la fonació.
Amb motiu del Dia Nacional de la Miastènia Gravis l’Associació de pacients AMES ha organitzat un seguit d’activitats informatives per donar visibilitat a aquesta malaltia.
La miastènia greu (MG) és una malaltia neuromuscular poc freqüent que es caracteritza perquè els pacients tenen fatigabilitat i debilitat dels músculs voluntaris. La debilitat pot afectar qualsevol múscul incloent músculs oculars, de les extremitats i músculs vitals, responsables de la funció respiratòria, de la deglució i de la fonació.
Article Complet
Eduard Gallardo ha estat nomenat cap de grup de la U762 CIBERER de la Unitat de Malalties Neuromusculars de l’Hospital de Sant Pau de Barcelona en substitució de la Dra.Isabel Illa. Aquest equip d’investigació està especialitzat en malalties neuromusculars.
El Dr Gallardo treballa des de 1993 en el camp de les neuropaties desinmunes, miastènia, miopaties inflamatòries i distròfies musculars, i més específicament en les disferlinopaties. Té més de 100 publicacions (PubMed) en el camp de les malalties neuromusculars i ha estat investigador principal de 12 projectes d’investigació.
Eduard Gallardo ha estat nomenat cap de grup de la U762 CIBERER de la Unitat de Malalties Neuromusculars de l’Hospital de Sant Pau de Barcelona en substitució de la Dra.Isabel Illa. Aquest equip d’investigació està especialitzat en malalties neuromusculars.
El Dr Gallardo treballa des de 1993 en el camp de les neuropaties desinmunes, miastènia, miopaties inflamatòries i distròfies musculars, i més específicament en les disferlinopaties. Té més de 100 publicacions (PubMed) en el camp de les malalties neuromusculars i ha estat investigador principal de 12 projectes d’investigació.
Article Complet
A causa de l’alerta sanitària mundial que es viu aquests dies davant la pandèmia per SARS-COV2, un grup d’experts mundials en Miastènia Gravis ha desenvolupat un document de recomanacions dirigits a pacients i metges. En el document adjunt trobareu recomanacions generals per a pacients amb Miastenia Gravis i Síndrome de Eaton-Lambert, indicacions per a inici de tractament i per a pacients en assaig clínic.
A causa de l’alerta sanitària mundial que es viu aquests dies davant la pandèmia per SARS-COV2, un grup d’experts mundials en Miastènia Gravis ha desenvolupat un document de recomanacions dirigits a pacients i metges. En el document adjunt trobareu recomanacions generals per a pacients amb Miastenia Gravis i Síndrome de Eaton-Lambert, indicacions per a inici de tractament i per a pacients en assaig clínic.
Article Complet
L’Associació de Pacients AMES (Asociación Miastenia de España) juntament amb la Unitat de Malalties Neuromusculars celebressin, amb motiu del dia de les Malalties Minoritàries, el XIII Congrés Nacional de Miastènia Gravis. Aquesta trobada tindrà lloc els dies 28 i 29 de febrer a la sala d’actes de l’Hospital de Sant Pau. Durant dos dies neuròlegs especialistes en miastènia gravis, psicòlegs i pacients s’ajuntaran per compartir coneixements i experiències.
L’Associació de Pacients AMES (Asociación Miastenia de España) juntament amb la Unitat de Malalties Neuromusculars celebressin, amb motiu del dia de les Malalties Minoritàries, el XIII Congrés Nacional de Miastènia Gravis. Aquesta trobada tindrà lloc els dies 28 i 29 de febrer a la sala d’actes de l’Hospital de Sant Pau. Durant dos dies neuròlegs especialistes en miastènia gravis, psicòlegs i pacients s’ajuntaran per compartir coneixements i experiències.
Article Complet
Qui som
Equip Clínic
Equip Recerca
Ricard Rojas García
MD PhD – Neuròleg Adjunt
Neuròleg
Luis Querol Gutiérrez
MD PhD – Neuròleg Adjunt
Neuròleg
Montse Olivé
Neurofisióloga adjunta
Neurofisióloga adjunta
Janina Turon i Sans
Neurofisióloga adjunta
Neurofisióloga adjunta
Elena Cortés Vicente
Neuròloga - Investigadora Post-doctoral
Neuròloga
Elba Pascual Goñi
Neuròloga i investigadora pre-doctoral
Neuròloga
Lorena Martín Aguilar
Neuròloga i investigadora pre-doctoral
Neuròloga
Jorge Alonso Pérez
Neuròleg i investigador pre-doctoral
Neuròleg i investigador pre-doctoral
Rodrigo Álvarez Velasco
Neuròleg i investigador pre-doctoral
Neuròleg i investigador pre-doctoral
Francesc Pla Juncà
Coordinador del Registre espanyol de Malalties Neuromusculars
Coordinador del Registre espanyol de Malalties Neuromusculars
Concepción Escola
Infermera Assistencial - Gestora de casos
Infermera
Eduard Gallardo Vigo
PhD - Investigador Sènior
Investigador Sènior
Noemi de Luna Salvà
PhD – Investigadora post-doctoral CIBERER
Investigadora
Jordi Díaz Manera
MD PhD - Neuròleg Adjunt
Neuròleg Adjunt
Xavier Suárez-Calvet
PhD - Investigador Post-doctoral
Investigador Post-doctoral
David Reyes Leiva
Investigador en malalties neuromusculars
Investigador en malalties neuromusculars
Cinta Lleixà
Investigadora pre-doctoral
Investigadora pre-doctoral
Publicacions
Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis.
Neurol Neuroimmunol Neuroinflamm
21/06/2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Am J Pathol
21/05/2022
Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study.
Muscle Nerve
01/05/2022
RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.
J Cachexia Sarcopenia Muscle
01/04/2022
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.
J Oncol Pharm Pract
11/02/2022
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.
Ann Clin Transl Neurol
01/02/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Prevalence of sarcopenia after remission of hypercortisolism and its impact on HRQoL.
Clin Endocrinol (Oxf)
01/11/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study.
J Neurol Neurosurg Psychiatry
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
Comment to "Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis".
J Neuroimmunol
15/09/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
Clinical characteristics and outcomes of thymoma-associated myasthenia gravis.
Eur J Neurol
01/06/2021
Chronic inflammatory demyelinating polyneuropathy with hypertrophic nerves.
J Peripher Nerv Syst
01/06/2021
Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder.
Patient Prefer Adherence
12/04/2021
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease.
Neuromuscul Disord
01/04/2021
A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?
J Peripher Nerv Syst
01/03/2021
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients.
J Neurol Neurosurg Psychiatry
05/11/2020
The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases.
Curr Opin Neurol
01/10/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy.
Neurobiol Aging
01/08/2020
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis.
Neurol Neuroimmunol Neuroinflamm
15/07/2020
COVID-19-associated ophthalmoparesis and hypothalamic involvement.
Neurol Neuroimmunol Neuroinflamm
25/06/2020
Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy.
Neurol Neuroimmunol Neuroinflamm
02/06/2020
Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy.
Ann Clin Transl Neurol
01/06/2020
Thigh Muscle Fat Infiltration Is Associated With Impaired Physical Performance Despite Remission in Cushing's Syndrome.
J Clin Endocrinol Metab
01/05/2020
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
Neurologia (Engl Ed)
01/04/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Boundaries of chronic inflammatory demyelinating polyradiculoneuropathy.
J Peripher Nerv Syst
01/03/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies.
J Neurol Neurosurg Psychiatry
01/02/2020
APP-derived peptides reflect neurodegeneration in frontotemporal dementia.
Ann Clin Transl Neurol
01/12/2019
Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
Curr Opin Neurol
01/10/2019
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Qual Life Res
01/08/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Identification of serum microRNAs as potential biomarkers in Pompe disease.
Ann Clin Transl Neurol
01/07/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
J Neurol Neurosurg Psychiatry
01/05/2019
Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study.
J Neurol Neurosurg Psychiatry
01/11/2018
Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials.
J Neurol Neurosurg Psychiatry
01/10/2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
Modified Yarham and Smith scores for pathogenicity assessment of mtDNA tRNA variants - Response.
Neuromuscul Disord
01/04/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Head and voice tremor improving with immunotherapy in an anti-NF155 positive CIDP patient.
Ann Clin Transl Neurol
07/03/2018
Corpus callosum agenesis, myopathy and pinpoint pupils: consider Stormorken syndrome.
Eur J Neurol
01/02/2018
MRI in sarcoglycanopathies: a large international cohort study.
J Neurol Neurosurg Psychiatry
01/01/2018
Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
J Neuroinflammation
16/11/2017
Early diagnosis of amyotrophic lateral sclerosis mimic syndromes: pros and cons of current clinical diagnostic criteria.
Amyotroph Lateral Scler Frontotemporal Degener
01/08/2017
RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Arthritis Res Ther
24/07/2017
The Clinical Outcome Study for dysferlinopathy: An international multicenter study.
Neurol Genet
04/08/2016
Does ability to walk reflect general functionality in inflammatory neuropathies?
J Peripher Nerv Syst
01/06/2016
Bethlem Myopathy Phenotypes and Follow Up: Description of 8 Patients at the Mildest End of the Spectrum.
J Neuromuscul Dis
27/05/2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis.
Ann Clin Transl Neurol
27/04/2016
Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.
J Neuroimmunol
15/02/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes.
Neuromuscul Disord
01/01/2016
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) ).
J Peripher Nerv Syst
01/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.
J Inherit Metab Dis
01/03/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
Neuromuscul Disord
01/12/2014
Comprehensive care of amyotrophic lateral sclerosis patients: a care model.
Arch Bronconeumol
01/12/2013
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.
Orphanet J Rare Dis
23/10/2012
Trunk muscle involvement in late-onset Pompe disease: study of thirty patients.
Neuromuscul Disord
01/10/2012
Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.
J Peripher Nerv Syst
01/06/2012
Unique post-exercise electrophysiological test results in a new Andersen-Tawil syndrome mutation.
Clin Neurophysiol
01/12/2011
Revised normative values for grip strength with the Jamar dynamometer.
J Peripher Nerv Syst
01/03/2011
Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal.
J Neurol Neurosurg Psychiatry
01/06/2010
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.
J Clin Invest
01/01/2010
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Severe Guillain-Barré syndrome: sorting out the pathological hallmark in an electrophysiological axonal case.
J Peripher Nerv Syst
01/03/2009
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.
J Neuroimmunol
15/09/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance.
J Neuroimmunol
01/11/2001
Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.
J Neuropathol Exp Neurol
01/09/2001
Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Rev Neurol (Paris)
01/05/2001
HIV-associated polymyositis with life-threatening myocardial and esophageal involvement.
Arch Intern Med
10/05/1999
Dermatomyositis, polymyositis and inclusion body myositis: current concepts.
Rev Neurol (Paris)
01/01/1998
Antiganglioside antibodies in patients with acute polio and post-polio syndrome.
Ann N Y Acad Sci
25/05/1995
Post-polio syndrome: concepts in clinical diagnosis, pathogenesis, and etiology.
Adv Neurol
01/01/1991
Sensory neuropathy as the initial manifestation of primary biliary cirrhosis.
J Neurol Neurosurg Psychiatry
01/11/1989
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 983
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 983
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 984
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 984
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Am J Pathol
21/05/2022
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.
Ann Clin Transl Neurol
01/02/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Qual Life Res
01/08/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Bethlem Myopathy Phenotypes and Follow Up: Description of 8 Patients at the Mildest End of the Spectrum.
J Neuromuscul Dis
27/05/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.
J Peripher Nerv Syst
01/06/2012
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance.
J Neuroimmunol
01/11/2001
Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Rev Neurol (Paris)
01/05/2001
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1027
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1027
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1028
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1028
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Am J Pathol
21/05/2022
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.
Ann Clin Transl Neurol
01/02/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Qual Life Res
01/08/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Bethlem Myopathy Phenotypes and Follow Up: Description of 8 Patients at the Mildest End of the Spectrum.
J Neuromuscul Dis
27/05/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.
J Peripher Nerv Syst
01/06/2012
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance.
J Neuroimmunol
01/11/2001
Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Rev Neurol (Paris)
01/05/2001